Lorenc-Koci, E.; Lenda, T.; Konieczny, J.; Jantas, D.; Domin, H.
Cinnarizine, a Calcium Channel Blocker, Partially Prevents the Striatal Dopamine Decline and Loss of Nigral Dopamine Neurons in the Lactacystin-Induced Rat Model of Parkinson’s Disease. Int. J. Mol. Sci. 2025, 26, 8833.
https://doi.org/10.3390/ijms26188833
AMA Style
Lorenc-Koci E, Lenda T, Konieczny J, Jantas D, Domin H.
Cinnarizine, a Calcium Channel Blocker, Partially Prevents the Striatal Dopamine Decline and Loss of Nigral Dopamine Neurons in the Lactacystin-Induced Rat Model of Parkinson’s Disease. International Journal of Molecular Sciences. 2025; 26(18):8833.
https://doi.org/10.3390/ijms26188833
Chicago/Turabian Style
Lorenc-Koci, Elżbieta, Tomasz Lenda, Jolanta Konieczny, Danuta Jantas, and Helena Domin.
2025. "Cinnarizine, a Calcium Channel Blocker, Partially Prevents the Striatal Dopamine Decline and Loss of Nigral Dopamine Neurons in the Lactacystin-Induced Rat Model of Parkinson’s Disease" International Journal of Molecular Sciences 26, no. 18: 8833.
https://doi.org/10.3390/ijms26188833
APA Style
Lorenc-Koci, E., Lenda, T., Konieczny, J., Jantas, D., & Domin, H.
(2025). Cinnarizine, a Calcium Channel Blocker, Partially Prevents the Striatal Dopamine Decline and Loss of Nigral Dopamine Neurons in the Lactacystin-Induced Rat Model of Parkinson’s Disease. International Journal of Molecular Sciences, 26(18), 8833.
https://doi.org/10.3390/ijms26188833